Herbert Jamnig

1.8k total citations · 1 hit paper
22 papers, 1.4k citations indexed

About

Herbert Jamnig is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Biomedical Engineering. According to data from OpenAlex, Herbert Jamnig has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 7 papers in Biomedical Engineering. Recurrent topics in Herbert Jamnig's work include Advanced Chemical Sensor Technologies (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Herbert Jamnig is often cited by papers focused on Advanced Chemical Sensor Technologies (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Herbert Jamnig collaborates with scholars based in Austria, Switzerland and Germany. Herbert Jamnig's co-authors include Wolfgang Hilbe, H. Denz, Michael Fiegl, Clemens Ager, Martin Hackl, Wojciech Filipiak, Anton Amann, Martin Klieber, Bogusław Buszewski and Wolfram Miekisch and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Herbert Jamnig

22 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Noninvasive detection of lung cancer by analysis of exhaled breath

2009 480 citations Clemens Ager, Martin Klieber et al. BMC Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Herbert Jamnig Austria	14	1.0k	405	355	305	257	22	1.4k
Roger A. Maxfield United States	11	852 0.9×	338 0.8×	301 0.8×	225 0.7×	367 1.4×	13	1.2k
Nima Abbassi‐Ghadi United Kingdom	19	411 0.4×	420 1.0×	98 0.3×	465 1.5×	192 0.7×	37	1.4k
Khushman Taunk India	14	351 0.4×	226 0.6×	101 0.3×	386 1.3×	42 0.2×	33	733
Robert P. Oda United States	20	532 0.5×	370 0.9×	102 0.3×	267 0.9×	14 0.1×	30	1.0k
Lyudmila V. Bel’skaya Russia	14	113 0.1×	20 0.0×	30 0.1×	174 0.6×	63 0.2×	84	561
Jiayi Lan Switzerland	15	168 0.2×	158 0.4×	37 0.1×	375 1.2×	25 0.1×	22	773
María del Pilar Chantada‐Vázquez Spain	15	161 0.2×	139 0.3×	35 0.1×	248 0.8×	40 0.2×	34	662
Jae‐Chan Ryu South Korea	8	54 0.1×	216 0.5×	25 0.1×	278 0.9×	94 0.4×	38	857
Dongyu Li China	14	80 0.1×	59 0.1×	46 0.1×	250 0.8×	61 0.2×	51	695

Countries citing papers authored by Herbert Jamnig

Since Specialization

Citations

This map shows the geographic impact of Herbert Jamnig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert Jamnig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert Jamnig more than expected).

Fields of papers citing papers by Herbert Jamnig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert Jamnig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert Jamnig. The network helps show where Herbert Jamnig may publish in the future.

Co-authorship network of co-authors of Herbert Jamnig

This figure shows the co-authorship network connecting the top 25 collaborators of Herbert Jamnig. A scholar is included among the top collaborators of Herbert Jamnig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herbert Jamnig. Herbert Jamnig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stein, Markus, Herbert Jamnig, Sabine Scholl‐Bürgi, et al.. (2018). Tolerability of inhaled N-chlorotaurine in humans: a double-blind randomized phase I clinical study. Therapeutic Advances in Respiratory Disease. 12. 3270513995–3270513995. 20 indexed citations

Hilbe, Wolfgang, Georg Pall, Florian Kocher, et al.. (2015). Multicenter Phase II Study Evaluating Two Cycles of Docetaxel, Cisplatin and Cetuximab as Induction Regimen Prior to Surgery in Chemotherapy-Naive Patients with NSCLC Stage IB-IIIA (INN06-Study). PLoS ONE. 10(5). e0125364–e0125364. 7 indexed citations

Fiegl, Michael, Andreas Pircher, Gabriele Gamerith, et al.. (2014). Small steps of improvement in small-cell lung cancer (SCLC) within two decades: A comprehensive analysis of 484 patients. Lung Cancer. 84(2). 168–174. 23 indexed citations

Pircher, Andreas, Gabriele Gamerith, Arno Amann, et al.. (2014). Neoadjuvant chemo-immunotherapy modifies CD4+CD25+ regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patients. Lung Cancer. 85(1). 81–87. 44 indexed citations

Filipiak, Wojciech, Anna Filipiak, Andreas Sponring, et al.. (2014). Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers. Journal of Breath Research. 8(2). 27111–27111. 129 indexed citations

Kocher, Florian, Wolfgang Hilbe, Andreas Seeber, et al.. (2014). Longitudinal analysis of 2293 NSCLC patients: A comprehensive study from the TYROL registry. Lung Cancer. 87(2). 193–200. 122 indexed citations

Fiegl, Michael, Andreas Pircher, William Sterlacci, et al.. (2013). The TYROL Study SCLC Project: retrospective analysis of clinical features and therapeutic outcome in 484 small cell lung cancer patients diagnosed 1991 - 2011. Pneumologie. 67(5). 2 indexed citations

Filipiak, Wojciech, Veronika Ruzsányi, Paweł Mochalski, et al.. (2012). Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants. Journal of Breath Research. 6(3). 36008–36008. 172 indexed citations

Fuchs, Dietmar, Herbert Jamnig, Martin Klieber, et al.. (2012). Decline of exhaled isoprene in lung cancer patients correlates with immune activation. Journal of Breath Research. 6(2). 27101–27101. 27 indexed citations

10.

Sterlacci, William, Dominik Wolf‎, Spasenija Savic, et al.. (2011). High transforming growth factor β expression represents an important prognostic parameter for surgically resected non–small cell lung cancer. Human Pathology. 43(3). 339–349. 35 indexed citations

11.

Pircher, Andreas, Ernst Ulsperger, Herbert Jamnig, et al.. (2011). Basic clinical parameters predict gefitinib efficacy in non-small cell lung cancer.. PubMed. 31(9). 2949–55. 16 indexed citations

12.

Sterlacci, William, Michael Fiegl, Wolfgang Hilbe, et al.. (2010). Deregulation of p27 and Cyclin D1/D3 Control Over Mitosis Is Associated with Unfavorable Prognosis in Non-small Cell Lung Cancer, as Determined in 405 Operated Patients. Journal of Thoracic Oncology. 5(9). 1325–1336. 43 indexed citations

13.

Amann, Arno, Magdalena Ligor, Tomasz Ligor, et al.. (2010). Analysis of exhaled breath for screening of lung cancer patients. memo - Magazine of European Medical Oncology. 3(3). 106–112. 37 indexed citations

14.

Ligor, Magdalena, Tomasz Ligor, Clemens Ager, et al.. (2009). Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry. Clinical Chemistry and Laboratory Medicine (CCLM). 47(5). 550–60. 220 indexed citations

15.

Ager, Clemens, Martin Klieber, Konrad Schwarz, et al.. (2009). Noninvasive detection of lung cancer by analysis of exhaled breath. BMC Cancer. 9(1). 348–348. 480 indexed citations breakdown →

16.

Sterlacci, William, et al.. (2008). Idiopathic Systemic Amyloidosis Primarily Affecting the Lungs with Fatal Pulmonary Haemorrhage due to Vascular Involvement. Pathology & Oncology Research. 15(1). 133–136. 9 indexed citations

17.

Fiegl, Michael, Wolfgang Hilbe, Jutta Auberger, et al.. (2008). Twelve-year retrospective analysis of lung cancer—The TYROL Study: Daily routine in 1,424 patients (1995–2006). Journal of Clinical Oncology. 26(15_suppl). 19063–19063. 17 indexed citations

18.

Fiegl, Michael, August Zabernigg, Georg Pall, et al.. (2007). Das kleinzellige Bronchialkarzinom. Wiener klinische Wochenschrift. 119(23-24). 697–710. 3 indexed citations

19.

Hilbe, Wolfgang, K Aigner, Christian Dittrich, et al.. (2007). Expertenempfehlung 2006 zur rationalen Zweitlinien-Therapie beim nicht-kleinzelligen Bronchuskarzinom. Wiener klinische Wochenschrift. 119(7-8). 259–266. 9 indexed citations

20.

Wick, Georg, et al.. (1992). Complete Clarification of a Case of Farmer’s Lung. International Archives of Allergy and Immunology. 98(1). 89–92. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact